COO’s Insider Buy Signals Confidence in Tivic Health’s Entolimod
Insider buy by Tivic Health COO signals confidence in the company’s promising entolimod drug, Phase‑3 trial results, and BARDA partnership. Read the key insights for investors.
4 minutes to read